# IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

> **NCT07473960** · PHASE3 · RECRUITING · sponsor: **Innovent Biologics (Suzhou) Co. Ltd.** · enrollment: 198 (estimated)

## Conditions studied

- Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

## Interventions

- **DRUG:** IBI306
- **DRUG:** placebo
- **DRUG:** placebo
- **DRUG:** IBI306

## Key facts

- **NCT ID:** NCT07473960
- **Lead sponsor:** Innovent Biologics (Suzhou) Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-09-06
- **Final completion:** 2027-02-28
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07473960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07473960, "IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07473960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*